Asthma management in winter can be a challenge, but with the right tools, your symptoms will be better controlled. By getting ...

AZ’s Airsupra (albuterol and budesonide) – developed with Avillion – was approved by the FDA last year for as-needed treatment or prevention of asthma ... market for smart inhaler devices ...

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

Request To Download Free Sample of This Strategic Report@ COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of ...

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...

open image in gallery A senior woman uses her inhaler. New research has found that one in six US adults are stopped from taking their asthma medication as it has been prescribed due to its cost ...

Major companies in the dry powder inhaler market are focusing on innovation, developing products with muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD), and ...

According to Future Market Insights (FMI), the global asthma treatment market is poised for substantial growth, projected to hit USD 28.0 billion in 2024 and soar to USD 46.0 billion by 2034, with a ...

Technology Focus: Smart inhalers and eco-friendly propellants are driving innovations in the market. Disease Prevalence: Rising cases of asthma and COPD are a key determinant of demand.